Carl Zeiss Meditec AG ranks below the peer group median, with a split structural profile: strong valuation, but weak growth and profitability. The market setup has weakened, with clear trend damage and relative performance under pressure.
Peer-relative scores, weakest to strongest
Carl Zeiss Meditec AG develops and sells medical technology products, with a focus on devices for ophthalmology. The company operates globally in the medtech sector.
The market prices Carl Zeiss Meditec as a cyclically pressured laggard at a valuation discount, not as a resilient peer in the medtech sector. With EBITA margin at just 6.1% and revenue growth at -5.7% for H1 2025/26, the market actively penalizes the stock for its weak profitability and negative top-line momentum, reinforcing the perception of earnings risk—especially given ongoing regulatory hurdles in key markets like China. Within the medtech sector, Carl Zeiss Meditec stands out for declining revenues and regulatory setbacks in growth markets, while many peers maintain stable or growing results. As a result, the market continues to price the stock below peer levels and does not anticipate a near-term re-rating to sector norms. Only a sustained turnaround in both revenue growth AND margins—such as through successful cost savings and resolution of China regulatory issues—could break the peer-discount framing.
Break down AFX.DE's position across all dimensions with the full interactive tool.
This analysis is rule-based and descriptive. Peer-relative scores are derived from functional peer group comparisons using publicly available financial data. Scores reflect structural positioning only and do not constitute investment advice, a buy or sell recommendation, or a forecast of future performance. AssetNext peer scores are recalculated periodically as new data becomes available.
AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.
Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.
Because scores are peer-relative, the same company can have slightly different scores in different index universes. On comparison pages, both companies are shown within their shared peer universe wherever possible — so the scores are directly comparable. The peer basis is stated on each score card.
Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.